Compare Ginkgo Bioworks Holdings Inc (DNA) vs Global Payments Inc (GPN) Price & Performance

Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day. The technical outlook is bullish based on moving averages, while oscillators are neutral. Fundamentally, the company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with a negative net income margin of -219.6%. Recent news includes a partnership with TuneLab and a $17.5 million ARPA-H subcontract.

The outlook is challenged by persistent losses and negative cash flow, though strategic partnerships offer growth potential. Analyst sentiment is divided evenly between buy, hold, and sell ratings. Key risks include execution on profitability and high cash burn. The stock presents a speculative opportunity dependent on the company's ability to monetize its technology platform.

Global Payments (GPN) trades at $82.77, up 2.08% with neutral technical signals and bullish moving averages. The company shows strong earnings momentum with three consecutive quarterly beats, though 2026 projections indicate potential profitability challenges. Recent developments include the Genius platform expansion and Worldpay integration driving growth opportunities, while elevated debt levels and competitive pressures present headwinds.

The stock offers 24% upside to the $102.75 consensus target with strong analyst support (59% buy ratings), but investors face risks from declining 2026 profitability projections and rising debt-to-asset ratios. The company's digital payment initiatives provide growth catalysts, though execution risks and margin pressures require careful monitoring.